Gilpin Wealth Management’s Integra LifeSciences IART Stock Holding History

Gilpin Wealth Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$196	Hold	12	–	–	﹤0.01%	1127
2026 Q2	$216	Buy	+12	New	+$168	﹤0.01%	897
2026 Q1	–	Sell	-1	Closed	-$13	–	1036
2025 Q4	$13	Buy	+1	New	+$13	﹤0.01%	976

Other funds holding IART

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Planning Strategies Lancaster, Pennsylvania $169M AUM

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Gilpin Wealth Management's IART Position: Q3 2026 in Review

Gilpin Wealth Management held its Integra LifeSciences (IART) position steady in Q3 2026 at 12 shares worth $196. The position accounts for ﹤0.01% of the portfolio, ranked #1127.

Gilpin Wealth Management first reported a position in IART in Q4 2025 and has held it in 3 quarters since. The position peaked at $216 in Q2 2026. 5 funds tracked by Wall St. Rank hold IART as of Q3 2026.

Gilpin Wealth Management held 12 shares of Integra LifeSciences worth $196 as of Q3 2026.
Gilpin Wealth Management left its Integra LifeSciences share count unchanged in Q3 2026.
Integra LifeSciences made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #1127 holding.
Gilpin Wealth Management first reported a position in Integra LifeSciences in Q4 2025 and has held it in 3 quarters since.
Gilpin Wealth Management's Integra LifeSciences position peaked at $216 in Q2 2026.
5 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.